← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2005Last known activity
Feb 28, 2026
Timeline
1970s
- Jan 1, 1971
The National Cancer Center— Founded
Drugs by trial phase (51 distinct, 41 trials)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Breast Neoplasms
- Cancer Pain
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Lung Neoplasms
- Lymphoma
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, T-Cell
- Musculoskeletal Pain
- Myelodysplastic Syndromes
- Nasopharyngeal Carcinoma
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Osteosarcoma
- Pancreatic Neoplasms
- Preleukemia
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Vomiting
Recent trials (41)
- NCT07297654OfficialPhase 2Feb 28, 2026
- NCT07121478OfficialPhase 2Sep 23, 2025
- NCT06971965OfficialN/AJun 2, 2025
- NCT07037680OfficialPhase 2Jan 1, 2024
- NCT06135896Overall official - principal investigatorPhase 2Dec 10, 2023
- NCT05936658Overall official - principal investigatorPhase 3May 8, 2023
- NCT06466265OfficialPhase 1May 24, 2021
- NCT04611165Overall official - principal investigatorPhase 2Nov 15, 2019
- NCT04014257Overall official - principal investigatorPhase 1Jul 25, 2019
- NCT03808480Overall official - principal investigatorPhase 2Jan 23, 2019
- NCT03789617Overall official - principal investigatorPhase 1/Phase 2Dec 14, 2018
- NCT03612154Overall official - principal investigatorPhase 2Dec 1, 2018
- NCT03390946Overall official - principal investigatorPhase 2Feb 1, 2018
- NCT03262454Overall official - principal investigatorPhase 2Jan 22, 2018
- NCT03497702Overall official - principal investigatorPhase 2May 8, 2017
Details
- Founded
- Plainview, NY, US Jan 1, 1971
- Last known activity
- Feb 28, 2026